186 related articles for article (PubMed ID: 18622892)
1. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
Kaji H; Naito J; Inoue Y; Sowa H; Sugimoto T; Chihara K
Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
[TBL] [Abstract][Full Text] [Related]
2. Role of Smad3, acting independently of transforming growth factor-beta, in the early induction of Wnt-beta-catenin signaling by parathyroid hormone in mouse osteoblastic cells.
Inoue Y; Canaff L; Hendy GN; Hisa I; Sugimoto T; Chihara K; Kaji H
J Cell Biochem; 2009 Sep; 108(1):285-94. PubMed ID: 19582775
[TBL] [Abstract][Full Text] [Related]
3. Smad3 differently affects osteoblast differentiation depending upon its differentiation stage.
Kaji H; Naito J; Sowa H; Sugimoto T; Chihara K
Horm Metab Res; 2006 Nov; 38(11):740-5. PubMed ID: 17111301
[TBL] [Abstract][Full Text] [Related]
4. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
5. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells.
Maeda T; Matsunuma A; Kawane T; Horiuchi N
Biochem Biophys Res Commun; 2001 Jan; 280(3):874-7. PubMed ID: 11162604
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells.
Kwok S; Qin L; Partridge NC; Selvamurugan N
J Cell Biochem; 2005 Aug; 95(5):1002-11. PubMed ID: 15880704
[TBL] [Abstract][Full Text] [Related]
9. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells.
Mithani SK; Balch GC; Shiou SR; Whitehead RH; Datta PK; Beauchamp RD
J Surg Res; 2004 Apr; 117(2):296-305. PubMed ID: 15047135
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
Song CY; Kim BC; Lee HS
Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts.
Sowa H; Kaji H; Iu MF; Tsukamoto T; Sugimoto T; Chihara K
J Biol Chem; 2003 Dec; 278(52):52240-52. PubMed ID: 14517210
[TBL] [Abstract][Full Text] [Related]
12. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts.
Ohnaka K; Shimoda S; Nawata H; Shimokawa H; Kaibuchi K; Iwamoto Y; Takayanagi R
Biochem Biophys Res Commun; 2001 Sep; 287(2):337-42. PubMed ID: 11554731
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells.
Tobimatsu T; Kaji H; Sowa H; Naito J; Canaff L; Hendy GN; Sugimoto T; Chihara K
Endocrinology; 2006 May; 147(5):2583-90. PubMed ID: 16484320
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble factors induce the proliferation, alkaline phosphatase activity and transforming growth factor-beta signal in osteoblastic cells in the patient with hepatitis C-associated osteosclerosis.
Kaji H; Naito J; Sowa H; Sugimoto T; Chihara K
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):599-604. PubMed ID: 17177144
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
[TBL] [Abstract][Full Text] [Related]
16. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
Borton AJ; Frederick JP; Datto MB; Wang XF; Weinstein RS
J Bone Miner Res; 2001 Oct; 16(10):1754-64. PubMed ID: 11585338
[TBL] [Abstract][Full Text] [Related]
17. Concentration-dependent bifunctional effect of TGF-beta 1 on immunoglobulin production: a role for Smad3 in IgA production in vitro.
McKarns SC; Letterio JJ; Kaminski NE
Int Immunopharmacol; 2003 Dec; 3(13-14):1761-74. PubMed ID: 14636827
[TBL] [Abstract][Full Text] [Related]
18. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
Ogunwobi OO; Beales IL
Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
[TBL] [Abstract][Full Text] [Related]
19. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
20. beta-Cryptoxanthin stimulates cell proliferation and transcriptional activity in osteoblastic MC3T3-E1 cells.
Uchiyama S; Yamaguchi M
Int J Mol Med; 2005 Apr; 15(4):675-81. PubMed ID: 15754031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
